On the role of explanations in machine learning prediction of nonalcoholic steatohepatitis
Open Access
- 25 July 2025
- journal article
- research article
- Published by Springer Nature in Progress in Artificial Intelligence
- Vol. 15 (1) , 35-56
Abstract
Nonalcoholic steatohepatitis (NASH) is a common disease that ultimately can lead to the development of end-stage liver disease, cirrhosis, or hepatocellular carcinoma. An early prediction of NASH provides an opportunity to make an appropriate strategy for prevention, early diagnosis, and treatment. The most accurate approach for NASH diagnostics is a liver biopsy, which can lead to various complications for the patient. Many papers have studied non-invasive machine learning (ML)-driven approaches to early non-invasive NASH prediction; however, to the best of our knowledge, none of the works considered the problem of explainability of the trained ML models to the medical experts. In this work, we address this issue. We use the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) nonalcoholic fatty liver disease adult database to train different ML models and propose the technique to explain their predictions. We compare the explanations obtained from a transparent model (Decision Tree) and a non-transparent model (Random Forest). Furthermore, we analyze the quality of explanation prediction by objective means and with a user study involving 11 medical practitioners. Our findings show that there is no significant difference in the perception of explanation obtained from transparent and non-transparent models, and that the explanation of the models’ predictions slightly increases their usability and trustworthiness for real practitioners, enhancing their practical adoption in clinical settings.Keywords
This publication has 59 references indexed in Scilit:
- Evaluation of Human-Understandability of Global Model Explanations Using Decision Tree2024
- Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based populationEuropean Radiology, 2023
- A survey of Bayesian Network structure learningArtificial Intelligence Review, 2023
- Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosisJGH Open, 2022
- Clinical Decision-Support Systems2021
- Bayesian networks in healthcare: What is preventing their adoption?Artificial Intelligence in Medicine, 2021
- Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLDJournal of Hepato-Biliary-Pancreatic Sciences, 2021
- An incremental explanation of inference in Bayesian networks for increasing model trustworthiness and supporting clinical decision makingArtificial Intelligence in Medicine, 2020
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological AssociationHepatology, 2012